Towards novel anti-cancer agents: Tetrahydroquinoline-based small-molecules as selective Mcl-1 inhibitors

被引：0
|
作者：
Chen, Lijia [1 ]
Yap, Jeremy L. [1 ]
Gallagher, Catherine [2 ,3 ]
Walensky, Loren D. [2 ,3 ]
Fletcher, Steven [1 ]
机构：
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA 02215 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 247卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
326-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Small mitochondria-targeting molecules as anti-cancer agents
    Wang, Feng
    Ogasawara, Marcia A.
    Huang, Peng
    MOLECULAR ASPECTS OF MEDICINE, 2010, 31 (01) : 75 - 92
  • [22] Discovery of novel tricyclic Mcl-1 inhibitors that exhibit selective anti-proliferative activity and in vivo efficacy
    Lee, Taekyu
    Tarr, James
    Zhao, Bin
    Bian, Zhiguo
    Shaw, Subrata
    Belmar, Johannes
    Arnold, Allison
    Sensintaffar, John
    Moore, William
    Stott, Gordon
    Hollingshead, Melinda
    Srivastava, Apurva
    Thomas, Craig
    Davis, Myrtle
    Rossanese, Olivia
    Olejniczak, Edward
    Fesik, Stephen
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [23] Small molecules targeting Mcl-1: the search for a silver bullet in cancer therapy
    Nhu, Duong
    Lessene, Guillaume
    Huang, David C. S.
    Burns, Christopher J.
    MEDCHEMCOMM, 2016, 7 (05) : 778 - 787
  • [24] Preclinical evaluation of AMG 176, a novel, potent and selective Mcl-1 inhibitor with robust anti-tumor activity in Mcl-1 dependent cancer models
    Caenepeel, Sean R.
    Belmontes, Brian
    Sun, Jan
    Coxon, Angela
    Moody, Gordon
    Hughes, Paul E.
    CANCER RESEARCH, 2017, 77
  • [25] Towards novel, benzodiazepine-based a-helix mimetics as specific inhibitors of the Mcl-1 oncoprotein
    Jung, Kwan-Young
    Chen, Lijia
    Yu, Wenbo
    Yap, Jeremy L.
    Cao, Xiaobo
    Smythe, Roy W.
    MacKerell, Alexander D.
    Fletcher, Steven
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [26] Design, synthesis and evaluation of novel, selective carbonic anhydrase IX inhibitors as anti-cancer agents
    Wang, R.
    Glassbrook, L.
    Bryce, R.
    Stratford, I.
    Supuran, C.
    Jaffar, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 53 - 54
  • [27] Mcl-1 depletion enhances anti-cancer drug-induced apoptosis in gastroenteric cancer cells
    Higuchi, Hajime
    Iizuka, Hideko
    Izumiya, Motoko
    Takaishi, Hiromasa
    Hibi, Toshifumi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S142 - S142
  • [28] Target validation and structural optimization of selective small molecule survivin inhibitors as potential anti-cancer agents
    Wang, Jin
    Xiao, Min
    Miller, Duane D.
    Li, Wei
    CANCER RESEARCH, 2015, 75
  • [29] Exploring indole derivatives as myeloid cell leukaemia-1 (Mcl-1) inhibitors with multi-QSAR approach: a novel hope in anti-cancer drug discovery
    Amin, Sk. Abdul
    Ghosh, Kalyan
    Mondal, Dipayan
    Jha, Tarun
    Gayen, Shovanlal
    NEW JOURNAL OF CHEMISTRY, 2020, 44 (40) : 17494 - 17506
  • [30] MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor
    Xiao, Yu
    Nimmer, Paul
    Sheppard, George S.
    Bruncko, Milan
    Hessler, Paul
    Lu, Xin
    Roberts-Rapp, Lisa
    Pappano, William N.
    Elmore, Steven W.
    Souers, Andrew J.
    Leverson, Joel D.
    Phillips, Darren C.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (08) : 1837 - 1847
12345